Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

463 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

The COMBAT HBV Feasibility Trial

NCT05705427

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Université Protestant au Congo Kinshasa, Democratic Republic of the Congo

View Trial Details

Completed

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

NCT06793826

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Investigational Site Number : 002 Cheonan, South Korea

Investigational Site Number : 001 Seoul, South Korea

View Trial Details

Completed

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

NCT04294433

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Laval University Research Hospital Center Québec, Quebec, Canada

Équipe de recherche en vaccination Québec, Quebec, Canada

View Trial Details

Completed

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

NCT05561673

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Leuven, Belgium

GSK Investigational Site Cologne, Germany

GSK Investigational Site Hamburg, Germany

GSK Investigational Site Magdeburg, Germany

View Trial Details

Completed

Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center

NCT05127187

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
Locations: CHU Nîmes Nîmes, France

View Trial Details

Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

NCT03365947

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Research Site 5 Camperdown, New South Wales, Australia

Research Site 4 Clayton, Victoria, Australia

Research Site 3 Melbourne, Victoria, Australia

Research Site 6 Nedlands, Western Australia, Australia

View Trial Details

Completed

Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe

NCT05541081

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Behavior, +42 more
Locations: Mbare polyclinic Harare, Zimbabwe

View Trial Details

Completed

Hepatitis B Virus Reactivation in COVID-19

NCT07154212

Conditions: Blood-Borne Infections, COVID-19 Pneumonia, Communicable Diseases, +14 more
Locations: University Medical Centre Ljubljana Ljubljana, Slovenia

View Trial Details

Completed

First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection

NCT04297917

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom

Oxford University Hospitals Nhs Foundation Trust Oxford, Oxfordshire, United Kingdom

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) Headington, Oxford, United Kingdom

Medicines Evaluations Unit Manchester, United Kingdom

View Trial Details

Completed

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

NCT04193189

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
Locations: Alabama CRS Birmingham, Alabama, United States

UCLA CARE Center CRS Los Angeles, California, United States

UCSD Antiviral Research Center San Diego, California, United States

Ucsf Hiv/Aids Crs San Francisco, California, United States

View all 41 locations

View Trial Details